The Indian drugmaker initiated the recall for the 200 milligram dosage form of the drug on Dec. 20 after it failed to meet dissolution specifications. About 11,618 bottles of bupropion hydrochloride were pulled from shelves, according to the report.
The Food and Drug Administration classified the recall as class-III, meaning the products violate FDA labeling or manufacturing rules, but are unlikely to cause any adverse health reactions.
More articles on supply chain:
Shifting drug production back to US could raise prices: 5 takeaways
5 ways to prepare your supply chain for a disaster
Mayo Clinic physician: A stripped down FDA would be ‘chaotic’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
